| Serial Number | 97191384 |
| Word Mark | CONJUALL |
| Filing Date | Monday, December 27, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, August 20, 2024 |
| Registration Number | 7477524 |
| Registration Date | Tuesday, August 20, 2024 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 4, 2024 |
| Goods and Services | Medicinal preparations for prevention and treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases, namely, antibodies, antibody conjugates and active ingredients and antibody conjugates; chemical reagents for medical use, especially chemical reagents for linking molecules for medical use; colostral antibodies and the chemical modifications and conjugates thereof for medical purposes and medical laboratory tests; drug delivery agents consisting of compounds that facilitate delivery of pharmaceuticals for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; biological preparations for pharmaceutical purposes for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; Chemical preparations for pharmaceutical purposes for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; medical pharmaceuticals for use in relation to the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; medical molecular diagnostic reagents for use in relation to the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; biopharmaceuticals for use in relation to the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; pharmaceutical preparations for treatment of rare diseases |
| Goods and Services | Scientific study and research in the field(s) of research on the subject of pharmaceuticals; development of pharmaceutical preparations and medicines; medical and pharmaceutical research services; biological research and analysis; chemical research and analysis; biochemical research and analysis; and scientific research in the nature of conducting clinical trials for others |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, January 4, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, January 4, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | LEGOCHEM BIOSCIENCES, INC. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Daejeon 34302 KR |
| Party Name | LEGOCHEM BIOSCIENCES, INC. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Daejeon 34302 KR |
| Party Name | LEGOCHEM BIOSCIENCES, INC. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Daejeon 34302 KR |
| Event Date | Event Description |
| Thursday, December 30, 2021 | NEW APPLICATION ENTERED |
| Wednesday, September 28, 2022 | ASSIGNED TO EXAMINER |
| Tuesday, January 4, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, September 29, 2022 | NON-FINAL ACTION WRITTEN |
| Thursday, September 29, 2022 | NON-FINAL ACTION E-MAILED |
| Thursday, September 29, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, March 17, 2023 | LETTER OF SUSPENSION E-MAILED |
| Wednesday, February 22, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, February 22, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, February 22, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, March 17, 2023 | SUSPENSION LETTER WRITTEN |
| Friday, March 17, 2023 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Thursday, September 14, 2023 | INQUIRY TO SUSPENSION E-MAILED |
| Thursday, September 14, 2023 | SUSPENSION INQUIRY WRITTEN |
| Thursday, September 14, 2023 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
| Wednesday, September 27, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, May 2, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, May 2, 2024 | ASSIGNED TO LIE |
| Thursday, May 2, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, May 2, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, May 15, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, June 4, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, June 4, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 20, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, August 20, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, December 12, 2023 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Wednesday, September 27, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, September 27, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |